Furthermore, whilst p16INK4a homozygous mutations are observed in 35% of acute lymphoblastic leukaemia (ALL) patients, p16INK4a deletion is not an independent prognostic factor in ALL [40]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.